S. Helsley et al., THE EFFECTS OF SIGMA, PCP, AND OPIATE RECEPTOR LIGANDS IN RATS TRAINED WITH IBOGAINE AS A DISCRIMINATIVE STIMULUS, Pharmacology, biochemistry and behavior, 59(2), 1998, pp. 495-503
Although the mechanism of action of ibogaine, a hallucinogen that may
be useful in the treatment of addiction, remains un known, receptor bi
nding studies suggest that ibogaine produces its effects via interacti
ons with multiple receptor types. In addition to serotonergic receptor
s, which have been studied previously with respect to ibogaine, likely
candidates include opiate, ate, sigma (sigma), and phencyclidine (PCP
) binding sites. In an attempt to determine which of these receptor in
teractions are involved in the in vivo effects of ibogaine, ligands fo
r sigma, PCP, and opiate receptors were assessed for their ability to
substitute for or to antagonize the ibogaine-induced discriminative st
imulus (10 mg/kg IF, 60 min presession) in Fischer-344 rats. Inter med
iate levels of generalization were observed with the subtype nonselect
ive sigma ligands 3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine [(+)-3-P
PP] (69.0%) and 1,3-di(2-tolyl)guanidine (DTG) (73.5%) but not with th
e sigma(1)-selective agents (+)-N-allylnormetazocine [(+)-SKF 10,047]
and (+)-pentazocine. These findings, along with observations that ibog
aine has appreciable affinity for sigma(2) receptors, suggest that the
se receptors may be involved in the ibogaine discriminative stimulus.
With regard to opiate receptors, neither morphine, the prototypic mu a
gonist, nor kappa selective agonists (bremazocine,and U-50488) substit
uted for ibogaine. However, intermediate levels of generalization were
observed with the mixed action opiates (-)-SKF 10,047 (78.9%), (+/-)-
pentazocine (73.9%), nalorphine (70.4%), and diprenorphine (75.0%) ind
icating a potential role for opiate receptors in the ibogaine stimulus
. Partial substitution was also observed with naltrexone (55.6%) but n
ot with naloxone or the selective kappa antagonist nor-binaltorphimine
(nor-BNI). These agents were largely ineffective as antagonists of th
e ibogaine cue, although naloxone produced a moderate but statisticall
y significant antagonism (69.8%). In addition, naloxone produced compl
ete antagonism of the ibogaine-appropriate responding elicited by both
(-)-SKF 10,047 (19.7%) and nalorphine (25.8%), whereas the ibogaine a
ppropriate responding produced by diprenorphine was only partially ant
agonized (44.4%). The latter observations taken together with the find
ing that both nalorphine (>100 mu M) and diprenorphine (30 mu M) have
extremely low affinity for sigma(2)-receptors, suggest that the ibogai
ne-appropriate responding produced by these agents is not mediated by
sigma(2) receptors. These findings imply that opiate effects may be in
volved in the ibogaine stimulus. In contrast to sigma(2) and opiate re
ceptors, ibogaine's reported interactions with NMDA receptors do not a
ppear to be involved in its discriminative stimulus, as neither PCP no
r MK-801 produced a significant level of ibogaine appropriate respondi
ng. Thus, the present study offers evidence that unlike NMDA receptors
,both sigma(2) and opiate receptors may be involved in the ibogaine di
scriminative stimulus. (C) 1998 Elsevier Science Inc.